Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomePfizer Inc.

      Pfizer Inc.

      Pfizer Stock Rises, Company to Provide Global Fund With up to 6 Million Paxlovid Therapy Courses to Treat COVID
      Investing News

      Pfizer Stock Rises, Company to Provide Global Fund With up to 6 Million Paxlovid Therapy Courses to Treat COVID

      September 22, 2022
      How Pfizer Emerged as the Winner in Bidding War for Global Blood Therapeuitcs
      Investing News

      How Pfizer Emerged as the Winner in Bidding War for Global Blood Therapeuitcs

      August 24, 2022
      Is Pfizer Stock a Ticking Time Bomb?
      Investing News

      Is Pfizer Stock a Ticking Time Bomb?

      August 4, 2022
      « 1 2 3

       

      LATEST NEWS

      • Investing News Intel’s Turnaround Gains Momentum
      • Investing News Volkswagen’s Earnings Reveal Market Trends
      • Investing News Dover’s Industrial Struggles
      • Investing News Honeywell’s Post-Spinoff Growth
      • Investing News Comcast Earnings Show Strength

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026